CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Mélissa Simard - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Mélissa Simard

OPENALEX: A5032116731↗ORCID: 0000-0001-6945-9619↗

Affiliations

Organizations

Institut universitaire de cardiologie et de pneumologie de Québecauthorship · CA Université Lavalauthorship · CA

Public evidence

5 connected articles

The Impact of the CB<sub>2</sub> Cannabinoid Receptor in Inflammatory Diseases: An Update.2024 · Europe PMC N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model.2023 · Europe PMC Current knowledge of the implication of lipid mediators in psoriasis.2022 · Europe PMC Expression and Functions of the CB<sub>2</sub> Receptor in Human Leukocytes.2022 · Europe PMC Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites <i>N</i>-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by Human Neutrophils and Eosinophils.2021 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.